234 related articles for article (PubMed ID: 29230931)
1. Temporal changes in glycaemic thresholds for treatment intensification in type 2 diabetes in an urban Australian setting: the Fremantle Diabetes Study.
Davis TME; Chubb SAP; Curtis BH; Barraclough H; Davis WA
Intern Med J; 2018 Oct; 48(10):1215-1221. PubMed ID: 29230931
[TBL] [Abstract][Full Text] [Related]
2. Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes Study.
Davis TM; Davis Cyllene Uwa Edu Au WA; Bruce DG
Med J Aust; 2006 Apr; 184(7):325-8. PubMed ID: 16584365
[TBL] [Abstract][Full Text] [Related]
3. Distinct trajectories of HbA
Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
[TBL] [Abstract][Full Text] [Related]
4. Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: analysis of continuous glucose monitoring data from the INITIATION study.
Manski-Nankervis J; Yates CJ; Blackberry I; Furler J; Ginnivan L; Cohen N; Jenkins A; Vasanthakumar S; Gorelik A; Young D; Best J; O'Neal D
Diabet Med; 2016 Jun; 33(6):803-11. PubMed ID: 26435033
[TBL] [Abstract][Full Text] [Related]
5. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
[TBL] [Abstract][Full Text] [Related]
6. What happens when patients require intensification from basal insulin? A retrospective audit of clinical practice for the treatment of type 2 diabetes from four Australian centres.
Fulcher G; Roberts A; Sinha A; Proietto J
Diabetes Res Clin Pract; 2015 Jun; 108(3):405-13. PubMed ID: 25887419
[TBL] [Abstract][Full Text] [Related]
7. Long-term sustainability of glycaemic achievements with second-line antidiabetic therapies in patients with type 2 diabetes: A real-world study.
Montvida O; Shaw JE; Blonde L; Paul SK
Diabetes Obes Metab; 2018 Jul; 20(7):1722-1731. PubMed ID: 29536608
[TBL] [Abstract][Full Text] [Related]
8. The relationship between glycated haemoglobin and blood glucose-lowering treatment trajectories in type 2 diabetes: The Fremantle Diabetes Study Phase II.
Davis TME; Davis W
Diabetes Obes Metab; 2024 Jan; 26(1):283-292. PubMed ID: 37795655
[TBL] [Abstract][Full Text] [Related]
9. Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA
Young TK; Li JW; Kang A; Heerspink HJL; Hockham C; Arnott C; Neuen BL; Zoungas S; Mahaffey KW; Perkovic V; de Zeeuw D; Fulcher G; Neal B; Jardine M
Diabetologia; 2021 Nov; 64(11):2402-2414. PubMed ID: 34448033
[TBL] [Abstract][Full Text] [Related]
10. Intensification patterns and the probability of HbA
Pantalone KM; Misra-Hebert AD; Hobbs TM; Ji X; Kong SX; Milinovich A; Weng W; Bauman JM; Ganguly R; Burguera B; Kattan MW; Zimmerman RS
Diabet Med; 2020 Jul; 37(7):1114-1124. PubMed ID: 30653705
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes.
Kim K; Unni S; Brixner DI; Thomas SM; Olsen CJ; Sterling KL; Mitchell M; McAdam-Marx C
Diabetes Obes Metab; 2019 Jul; 21(7):1725-1733. PubMed ID: 30848039
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of intensification therapies in Danes with Type 2 diabetes who use basal insulin: a population-based study.
Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
Diabet Med; 2017 Feb; 34(2):213-222. PubMed ID: 27279380
[TBL] [Abstract][Full Text] [Related]
13. Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
Lind M; Hirsch IB; Tuomilehto J; Dahlqvist S; Ahrén B; Torffvit O; Attvall S; Ekelund M; Filipsson K; Tengmark BO; Sjöberg S; Pehrsson NG
BMJ; 2015 Oct; 351():h5364. PubMed ID: 26512041
[TBL] [Abstract][Full Text] [Related]
14. Changes in HbA1c level over a 12-week follow-up in patients with type 2 diabetes following a medication change.
Hirst JA; Stevens RJ; Farmer AJ
PLoS One; 2014; 9(3):e92458. PubMed ID: 24667212
[TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries.
Khunti K; Caputo S; Damci T; Dzida GJ; Ji Q; Kaiser M; Karnieli E; Liebl A; Ligthelm RJ; Nazeri A; Orozco-Beltran D; Pan C; Ross SA; Svendsen AL; Vora J; Yale JF; Meneghini LF;
Diabetes Obes Metab; 2012 Dec; 14(12):1129-36. PubMed ID: 22830956
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
[TBL] [Abstract][Full Text] [Related]
17. Glycaemic control and mortality in older people with type 2 diabetes: The Fremantle Diabetes Study Phase II.
Bruce DG; Davis WA; Davis TME
Diabetes Obes Metab; 2018 Dec; 20(12):2852-2859. PubMed ID: 30003670
[TBL] [Abstract][Full Text] [Related]
18. Patient-level predictors of achieving early glycaemic control in Type 2 diabetes mellitus: a population-based study.
Svensson E; Baggesen LM; Thomsen RW; Lyngaa T; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
Diabet Med; 2016 Nov; 33(11):1516-1523. PubMed ID: 27412570
[TBL] [Abstract][Full Text] [Related]
19. Rates of glycaemic deterioration in a real-world population with type 2 diabetes.
Donnelly LA; Zhou K; Doney ASF; Jennison C; Franks PW; Pearson ER
Diabetologia; 2018 Mar; 61(3):607-615. PubMed ID: 29260253
[TBL] [Abstract][Full Text] [Related]
20. Self-Monitoring of Blood Glucose in Youth-Onset Type 2 Diabetes: Results From the TODAY Study.
Weinstock RS; Braffett BH; McGuigan P; Larkin ME; Grover NB; Walders-Abramson N; Laffel LM; Chan CL; Chang N; Schwartzman BE; Barajas RA; Celona-Jacobs N; Haymond MW;
Diabetes Care; 2019 May; 42(5):903-909. PubMed ID: 30833375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
